focus -WSS

focus

author：Wikipedia 2025-09-03 15:25:26 - browse：47

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： A new initiative will help leaders fight the next pandemic

explore

WSS

Senators tussle over abortion against the backdrop of a presidential campaign

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Drug companies' payments and gifts affect physicians' prescribing

Florida Supreme Court upholds state's abortion ban

Scientists uncover potential path to treating deadly childhood tumor

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Bright Health sells Medicare Advantage business to Molina

A new initiative will help leaders fight the next pandemic

Novavax promises a turnaround & Lilly roils the obesity market

Structure Therapeutics oral GLP

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

'Little Tech' descents on D.C., wanting a say in how AI is regulated

In age of alternative facts, a scholarly course on calling out crap

Medicare Advantage's lean provider networks lead CMS complaints

Alkermes shareholders re

Florida Supreme Court upholds state's abortion ban

hotspot

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Pancreatic cancer is often deadly, but new discoveries are raising hope

Republican states more likely to report Covid vaccine side effects

Republican states more likely to report Covid vaccine side effects

focus

explore

explore

hotspot